eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | fibrosarcoma |
| Comorbidity | C1261473|sarcomas |
| Sentences | 1 |
| PubMedID- 24314323 | It was recently shown that trabectedin, a dna-damaging agent approved for soft tissue sarcomas, inhibited the growth of mouse fibrosarcomas mainly by depleting monocytes and tams [137], suggesting that the antitumor efficacy of certain cytotoxic agents may partially rely on their ability to deplete pro-tumoral myeloid cells. |
Page: 1